Characteristics of IL-6 and TNF-α production by respiratory syncytial virus-infected macrophages in the neonate

Journal of Medical Virology

Volumn 48, Issue 2, 1996, Pages 199-203

  Matsuda, Kazuko ^a   Tsutsumi, Hiroyuki ^a   Sone, Shigemi ^a   Yoto, Yuko ^a   Oya, Kazuhiro ^a   Okamoto, Yoshitaka ^b   Ogra, Pearay L ^c   Chiba, Shunzo ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cytokine; IL 6; monocyte derived macrophages; mRNA; TNF

Indexed keywords

INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MONOCYTE; NEWBORN; NEWBORN INFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

ADULT; CELL LINE; CELLS, CULTURED; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INTERLEUKIN-6; MACROPHAGES; MONOCYTES; RESPIRATORY SYNCYTIAL VIRUSES; RNA, MESSENGER; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; SYNCYTIAL VIRUS;

EID: 0030019647     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199602)48:2<199::AID-JMV13>3.0.CO;2-A     Document Type: Article

References (24)

1. Anderson LJ, Hierholzer JC, Bingham PG, Stone YO (1985): Microneutralization test for respiratory syncytial virus based on an enzyme immunoassay. Journal of Clinical Microbiology 22:1050-1052.
2. Beagley KW, Eldridge JH, Lee F, Kiyono H, Everson MP, Koopman WJ, Hirano T, Kishimoto T, McGhee JR (1989): Interleukins and IgA synthesis: Human and murine interleukin 6 induce high IgA secretion in IgA-committed B cells. Journal of Experimental Medicine 169:2133-2148.
3. Becker S, Quay J, Soukup J (1991): Cytokine (tumor necrosis factor, IL-6 and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. Journal of Immunology 147:4307-4312.
4. Crowe JE Jr, Bui PT, London WT, Davis AR, Hung PP, Chanock RM, Murphy BR (1994): Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutants by introduction of additional attenuating mutations during chemical mutagenesis. Vaccine 12:691-699
5. Hayes PJ, Scott R, Wheeler J (1994): In vivo production of tumour necrosis factor-α and interleukin-6 in Balb/c mice inoculated intranasally with a high dose of respiratory syncytial virus. Journal of Medical Virology 42:323-329.
6. Kaul TN, Welliver RC, Wong DT, Udwadia RA, Riddlesberger K, Ogra PL (1981): Secretory antibody response to primary and secondary infection with respiratory syncytial virus infection. American Journal Diseases of Children 135:1013-1016.
7. Mayernik DG, Ul-haq A, Rinehart JJ (1983): Differentiation-associated alteration in human monocyte-macrophages accessory cell function. Journal of Immunology 130:2156-2160.
8. McIntosh K, Chanock RM (1990): Respiratory syncytial virus. In Fields BN, Knipe DM (eds): "Fields' Virology." New York: Raven Press, pp 1045-1072.
9. McIntosh K, Masters HB, Orr I, Chao RK, Barkin RM (1978): The immunologic response to infection with respiratory syncytial virus in infants. Journal of Infectious Diseases 138:24-32.
10. Midduia F, Villani A, Panuska JR, Dab I, Kolls JK, Merolla R, Ronchetti R (1993): Respiratory syncytial virus lung infection in infants: Immunoregulatory role of infected macrophages. Journal of Infectious Diseases 168:1515-1519.
11. Morahan PS, Connor JR, Leary KR (1985): Viruses and the versatile macrophages. British Medical Bulletin 41:15-21.
12. Murphy BR, Ailing DW, Snyder MH, Walsh EE, Prince GA, Chanock RM, Hemming VG, Rodriguez WL, Kim HW, Graham BS, Wright PF (1986a): Effect of age and pre-existing antibody of serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. Journal of Clinical Microbiology 24:894-898.
13. Murphy BR, Graham BS, Prince GA, Walsh EE, Chanock RM, Karzon DT, Wright PF (1986b): Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. Journal of Clinical Microbiology 23:1009-1014.
14. Oien NL, Brideau RJ, Walsh EE, Wathen MW (1994): Induction of local and systemic immunity against human respiratory syncytial viras using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine 12:731-735.
15. Okamoto Y, Kudo K, Ishizawa K, Ito E, Togawa K, Saito I, Moro I, Patel JA, Ogra PL (1993): Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules. Journal of Infectious Diseases 168:1277-1281.
16. Panuska JR, Cirino N, Midulla F, Despot JE, McFadden ER, Huang YT (1990a): Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. Journal of Clinical Investigation 86:113-119.
17. Panuska JR, Midulla F, Cirino N, Villani A, Gilbert IA, McFadden ER, Huang YT (1990b): Virus induced alteration in macrophage production of tumor necrosis factor and prostaglandin E2. American Journal of Physiology 259:L396-L402.
18. Parrott RH, Kim HW, Arrobio JO, Hodes DS, Murphy BR, Brandt CD, Camargo E, Chanock RM (1973): Epidemiology of respiratory syncytial virus infection in Washington D.C. II. Infection and disease with respect to age, immunologic status, race and sex. American Journal of Epidemiology 98:289-300.
19. Pringle BC (1987): Paramyxoviruses and diseases. In Russell WC, Almond JW (eds): "Molecular Basis of Virus Disease." Cambridge: Cambridge University Press, pp 51-90.
20. Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M (1994): The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561-563.
21. Richardson LS, Yolken RH, Belshe RB, Camargo E, Kim HW, Chanock RM (1978): Enzyme-linked immunosorbent assay for measurement of serological response to respiratory syncytial virus infection. Infection and Immunity 20:660-664.
22. Roberts NJ, Prill AH, Mann TN (1986): Interleukion 1 and interleukin 1 inhibitor production by human macrophages exposed to influenza virus or respiratory syncytial virus. Journal of Experimental Medicine 163:511-519.
23. Thomas ED, Ramberg RE, Sale GE, Sparkes RS, Golde DW (1976): Direct evidence for a bone marrow origin of the alveolar macrophages in man. Science 192:1016-1018.
24. Yamazaki H, Tsutsumi H, Matsuda K, Nagai K, Ogra PL, Chiba S (1994): Effect of maternal antibody on IgA antibody response in nasopharyngeal secretion in infants and children during primary respiratory syncytial virus infection. Journal of General Virology 75:2115-2119.